CellFE
Regenerative Medicine · Cell & Gene Therapy

CellFE news and milestones

CellFE: 16 headlines on record, 0 headlines in the last 90 days. Its story counts 12 milestones.

Data updated Nov 18, 2026 · Back to the company report
16Headlines
0In 90 days
12Milestones

Headlines

May 13, 20252025
Blog
CellFE and Made Scientific announce a strategic collaboration to generate pilot data on the CellFE High Volume Cyva System. The post CellFE and Made Scientific Announce Strategic…
Apr 30, 20252025
Blog
CellFE, a leader in non-viral gene editing technology, announces a strategic collaboration with the Harbottle Lab at German Cancer Research Center (DKFZ) and its spin-out company…
Mar 4, 20252025
Blog
CellFE releases a cGMP-compatible workflow to support highly efficient gene editing of iPSCs via a non-viral approach for cell therapy manufacturing. The post Application Note: E…
Jan 22, 20252025
News · YahooFinance
CellFE, a leader in non-viral gene editing technology, today announced the launch of its highly anticipated CellFE T-Rest ("Resting T Cell Kit"), a first-in-class cell manufactur…
Jan 17, 20252025
Blog
In the rapidly evolving field of cellular engineering, achieving complex gene edits with high efficiency and minimal workflow disruption remains a significant challenge. The post…
Jun 28, 20242024
Blog
CellFE Appoints Mike Rice to Board of Directors The post CellFE Announces Addition of Life Science Tools Veteran Mike Rice to Board of Directors appeared first on CellFE.
May 29, 20242024
Blog
CellFE announced today an upcoming presentation by CEO Alla Zamarayeva, PhD, at the International Society of Gene & Cell Therapy (ISCT) Annual Meeting, taking place May 29-June 1…
Apr 26, 20242024
Blog
CellFE announced today an upcoming presentation by CSO Todd Sulchek, PhD, at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting, taking place May 7-11, 2024 in…
Sep 27, 20232023
Press release
Endpoints News: CellFE raises $22M Series A to advance a new cell therapy manufacturing idea. Exclusive: The California-based startup CellFE has raised a $22 million Series A to…
Apr 1, 20202020
News · Pulse 2.0
CellFE, a company that is developing a microfluidics-based device for delivering gene-editing molecules, announced it raised $4.8 million in Series Seed funding.
Sources: the outlets named on each headline, each story once

Milestones

Each milestone is dated by its source: registers, filings, the press

How to cite

CellFE, News. Alion, Nov 18, 2026. https://alion.io/company/cellfebiotech/news

.json · .md · CC BY-SA 4.0